Regulation of type 1 plasminogen activator inhibitor gene expression in cultured bovine aortic endothelial cells. Induction by transforming growth factor-beta, lipopolysaccharide, and tumor necrosis factor-alpha.

作者: M Sawdey , T J Podor , D J Loskutoff

DOI: 10.1016/S0021-9258(18)81633-7

关键词:

摘要: Abstract Cultured bovine aortic endothelial cells (BAEs) synthesize and secrete type 1 plasminogen activator inhibitor (PAI-1), an Mr 50,000 glycoprotein which inhibits both urokinase tissue-type activators. The synthesis of PAI-1 in BAEs is positively regulated by a variety agents. To elucidate the mechanisms govern expression gene, total cytoplasmic RNA was prepared from analyzed Northern blotting using 1.3-kilobase (kb) human cDNA probe. Hybridization under conditions high stringency revealed two species, 3.0 1.6 kb length. ratio species approximately 4:1. 3.0-kb mRNA bound oligo(dT)-cellulose, whereas 1.6-kb form not, suggesting that latter lacked poly(A) terminus. Treatment with transforming growth factor beta (TGF-beta), bacterial lipopolysaccharide (LPS), or tumor necrosis alpha (TNF-alpha) markedly enhanced steady-state levels species. In each case, increases were detectable within h, maximal effects (i.e. greater than 30-fold increase) observed between 6 18 h treatment, followed decline to near-basal 48 h. response these agents dose-dependent, induction at concentrations 10 ng/ml TGF-beta, LPS, 25 TNF-alpha. Induction not blocked protein cycloheximide, de novo required. fact, treatment cycloheximide (2 micrograms/ml) alone also increased levels. combination TNF-alpha further accumulation mRNA. Nuclear transcription run-on experiments indicated elevated rate gene 20-30-fold template activity temporally correlated These data are consistent conclusion result primary on transcription.

参考文章(53)
H. Pannekoek, H. Veerman, H. Lambers, P. Diergaarde, C.L. Verweij, A.J. van Zonneveld, J.A. van Mourik, Endothelial plasminogen activator inhibitor (PAI): a new member of the Serpin gene family. The EMBO Journal. ,vol. 5, pp. 2539- 2544 ,(1986) , 10.1002/J.1460-2075.1986.TB04532.X
L. R. Lund, A. Riccio, P. A. Andreasen, L. S. Nielsen, P. Kristensen, M. Laiho, O. Saksela, F. Blasi, K. Danø, Transforming growth factor-beta is a strong and fast acting positive regulator of the level of type-1 plasminogen activator inhibitor mRNA in WI-38 human lung fibroblasts. The EMBO Journal. ,vol. 6, pp. 1281- 1286 ,(1987) , 10.1002/J.1460-2075.1987.TB02365.X
ED Sprengers, C Kluft, Plasminogen activator inhibitors. Blood. ,vol. 69, pp. 381- 387 ,(1987) , 10.1182/BLOOD.V69.2.381.BLOODJOURNAL692381
R Sznycer-Laszuk, T D Gelehrter, B J Cwikel, P L Coleman, U M Rafferty, P D Patel, Characterization of the dexamethasone-induced inhibitor of plasminogen activator in HTC hepatoma cells. Journal of Biological Chemistry. ,vol. 261, pp. 4352- 4357 ,(1986) , 10.1016/S0021-9258(17)35668-5
B Wiman, J Chmielewska, M Rånby, Inactivation of tissue plasminogen activator in plasma. Demonstration of a complex with a new rapid inhibitor. Journal of Biological Chemistry. ,vol. 259, pp. 3644- 3647 ,(1984) , 10.1016/S0021-9258(17)43143-7
J A van Mourik, D A Lawrence, D J Loskutoff, Purification of an inhibitor of plasminogen activator (antiactivator) synthesized by endothelial cells. Journal of Biological Chemistry. ,vol. 259, pp. 14914- 14921 ,(1984) , 10.1016/S0021-9258(17)42691-3
B S Knudsen, R L Nachman, Matrix plasminogen activator inhibitor. Modulation of the extracellular proteolytic environment. Journal of Biological Chemistry. ,vol. 263, pp. 9476- 9481 ,(1988) , 10.1016/S0021-9258(19)76565-X
R R Schleef, M P Bevilacqua, M Sawdey, M A Gimbrone, D J Loskutoff, Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor. Journal of Biological Chemistry. ,vol. 263, pp. 5797- 5803 ,(1988) , 10.1016/S0021-9258(18)60636-2